New data suggest statins as a potentially helpful class of drugs to fight COVID-19. Pointing to that study, Daniel Rader, MD, chair of Genetics, and David Fajgenbaum, MD, MBA, MSc, an assistant professor of Translational Medicine & Human Genetics, propose a framework for a systematic approach to drug repurposing for the novel coronavirus. To learn more, click Here
